FLIPing the apoptosis switch on in brain tumors using Troglitazone and TRAIL.
Hollander
Andrew B
AB
Department of Radiation Oncology, and Radiation Biology Program, Abramson Comprehensive Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Dorsey
Jay F
JF
D017209:Apoptosis / Q000187:drug effects; D053446:CASP8 and FADD-Like Apoptosis Regulating Protein / Q000378:metabolism; D002839:Chromans / Q000494:pharmacology / Q000627:therapeutic use; D005909:Glioblastoma / Q000188:drug therapy / Q000401:mortality / Q000473:pathology*; D005910:Glioma / Q000188:drug therapy / Q000401:mortality / Q000473:pathology*; D006801:Humans; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D016019:Survival Analysis; D045162:Thiazolidinediones / Q000494:pharmacology / Q000627:therapeutic use; D000077288:Troglitazone
D053446:CASP8 and FADD-Like Apoptosis Regulating Protein; D002839:Chromans; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand; D045162:Thiazolidinediones; D000077288:Troglitazone